BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19211844)

  • 21. Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells.
    Zhu N; Gu L; Li F; Zhou M
    Mol Cancer Ther; 2008 May; 7(5):1101-9. PubMed ID: 18483299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.
    Lu J; Guan S; Zhao Y; Yu Y; Woodfield SE; Zhang H; Yang KL; Bieerkehazhi S; Qi L; Li X; Gu J; Xu X; Jin J; Muscal JA; Yang T; Xu GT; Yang J
    Cancer Lett; 2017 Aug; 400():61-68. PubMed ID: 28455243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction.
    Kashii Y; Uchida M; Kirito K; Tanaka M; Nishijima K; Toshima M; Ando T; Koizumi K; Endoh T; Sawada K; Momoi M; Miura Y; Ozawa K; Komatsu N
    Blood; 2000 Aug; 96(3):941-9. PubMed ID: 10910908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin.
    Arimoto-Ishida E; Ohmichi M; Mabuchi S; Takahashi T; Ohshima C; Hayakawa J; Kimura A; Takahashi K; Nishio Y; Sakata M; Kurachi H; Tasaka K; Murata Y
    Endocrinology; 2004 Apr; 145(4):2014-22. PubMed ID: 14701673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis by L-NMMA, via FKHRL1/ROCK pathway in human gastric cancer cells.
    Wang YZ; Feng ZQ
    Biomed Environ Sci; 2006 Aug; 19(4):285-91. PubMed ID: 17044646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention.
    Peirce SK; Findley HW; Prince C; Dasgupta A; Cooper T; Durden DL
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):325-35. PubMed ID: 20972874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.
    Ushmorov A; Hogarty MD; Liu X; Knauss H; Debatin KM; Beltinger C
    Oncogene; 2008 May; 27(24):3424-34. PubMed ID: 18193081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
    Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
    J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of AKT and Foxo3a nuclear translocation.
    Picone P; Nuzzo D; Caruana L; Messina E; Scafidi V; Di Carlo M
    Free Radic Res; 2014 Dec; 48(12):1397-408. PubMed ID: 25179440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells.
    Schwab TS; Madison BB; Grauman AR; Feldman EL
    Apoptosis; 2005 Aug; 10(4):831-40. PubMed ID: 16133873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
    Hossain MM; Banik NL; Ray SK
    Exp Cell Res; 2012 Aug; 318(13):1597-610. PubMed ID: 22507272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
    Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
    Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.
    Azuhata T; Scott D; Griffith TS; Miller M; Sandler AD
    J Pediatr Surg; 2006 Aug; 41(8):1431-40. PubMed ID: 16863850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo.
    Geng X; Xie L; Xing H
    Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation.
    Cai W; He JC; Zhu L; Chen X; Striker GE; Vlassara H
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C145-52. PubMed ID: 18032526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
    Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
    Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.